We invest in biology + AI that enables human potential.

Here's what gives us our edge.

We find what others miss. Proprietary AI tools augment our network, helping us evaluate research quality, map commercial potential, and identify breakthrough science at scale. Additionally, our network of scientists and clinicians across 30+ institutions surfaces exceptional founders before they hit the traditional VC radar.

We understand the science. With a physician-scientist and Harvard Medical School faculty member as General Partner, we evaluate opportunities with clinical and research depth that most early-stage firms cannot match.

We help founders build. Beyond capital, we bring hands-on guidance in AI integration, leadership development, and operational scaling — drawn from experience advising hundreds of the world's leading organizations. Our portfolio companies don't just get funded. They get the tools, networks, and strategic support to grow.

Here's where we focus.

The molecular systems we once studied to treat disease are the very same systems we can now use to expand human capacity. In how we think, feel, and move — biology is no longer just a map of our limits. It's a toolkit to surpass them.

There has never been a bigger market opportunity for emerging life science companies. An aging demographic, a mental health crisis, advances in biological monitoring, and a scientific revolution are driving a CAGR of 12–14% across the sector.

So, what if there was a venture firm that leverages community to find, fund, and support the best life sciences startups from Day 1?

Legacy Venture Capital was founded to answer that question. We invest at pre-seed and seed in life sciences startups that enhance human potential — Performance, Vitality, Longevity, and Quality of Life.

Market Drivers

What We Look For